How many human screwworm cases will be reported in the United States in 2026?

Currently, it's difficult to directly compare the predictions in this market to specific analyst forecasts for human screwworm cases in 2026, as such forecasts are not widely available. However, prediction markets often aggregate diverse information and expert opinions, potentially offering a different perspective than traditional point estimates. If public health experts were to release forecasts, comparing them to the implied probabilities within this market would be a valuable exercise. The current trading activity suggests a focus on the possibility of new infestations, but the precise comparison requires external benchmarks.

This market resolves around Jan 8, 2027, with the outcome confirmed once the final reported number of human screwworm cases in the United States during 2026 is verifiable from credible public reporting. The Centers for Disease Control and Prevention (CDC) is the likely source for this data, but the specific reporting mechanism will be used to determine the final outcome. Traders should monitor official public health announcements as the resolution date approaches to understand the data being considered.

Several signals could significantly impact this market. Any confirmed reports of new human screwworm infestations in the United States would likely cause a substantial shift in prices, particularly for contracts representing higher case counts. Changes in veterinary surveillance programs for livestock, which are susceptible to screwworm, could also influence trader sentiment. Furthermore, public health announcements regarding preventative measures or outbreaks in nearby countries could move this market. Unexpected weather patterns impacting insect populations could also be a factor.